We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.21B
AUM Growth
-$47M
Cap. Flow
-$196M
Cap. Flow %
-4.66%
Top 10 Hldgs %
39.32%
Holding
820
New
134
Increased
52
Reduced
63
Closed
277

Sector Composition

Rank Sector Weight
1 Financials 18.69%
2 Technology 11.06%
3 Industrials 6.15%
4 Consumer Discretionary 5.6%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCNE
301
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
$1.5M 0.04%
150,000
LDTC
302
DELISTED
LeddarTech
LDTC
$1.49M 0.04%
300,000
NVCR icon
303
PUT
NovoCure
NVCR
$1.78B
$1.47M 0.03%
+20,000
New +$1.5M
MYNA
304
DELISTED
Mynaric AG American Depository Shares
MYNA
$1.44M 0.03%
340,000
TRDA icon
305
Entrada Therapeutics
TRDA
$282M
$1.42M 0.03%
105,000
VMC icon
306
Vulcan Materials
VMC
$36.7B
$1.33M 0.03%
+7,607
New +$1.3M
HHLA
307
DELISTED
HH&L Acquisition Co.
HHLA
$1.26M 0.03%
125,000
EBAC
308
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$1.26M 0.03%
125,000
ACI icon
309
Albertsons Companies
ACI
$5.58B
$1.24M 0.03%
+60,000
New +$1.32M
EQRX
310
DELISTED
EQRx, Inc. Common Stock
EQRX
$1.23M 0.03%
500,000
PTC icon
311
PTC
PTC
$15.2B
$1.21M 0.03%
+10,118
New +$1.21M
CYTK icon
312
Cytokinetics
CYTK
$10.4B
$1.15M 0.03%
25,000
PTCT icon
313
PTC Therapeutics
PTCT
$5.68B
$1.15M 0.03%
30,000
+10,000
+50% +$416K
AMPS
314
DELISTED
Altus Power
AMPS
$1.14M 0.03%
175,000
IWM icon
315
iShares Russell 2000 ETF
IWM
$81.5B
$1.13M 0.03%
+6,500
New +$1.16M
TSCO icon
316
Tractor Supply
TSCO
$16.8B
$1.12M 0.03%
+24,875
New +$1.06M
SUB icon
317
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$1.08M 0.03%
+10,395
New +$1.08M
SBUX icon
318
Starbucks
SBUX
$118B
$1.08M 0.03%
10,840
-47,358
-81% -$4.47M
PSNY icon
319
Polestar Automotive Holding UK
PSNY
$2.11B
$1.06M 0.03%
6,667
-5,892
-47% -$954K
TGNA
320
DELISTED
TEGNA Inc
TGNA
$1.06M 0.03%
50,000
+40,000
+400% +$806K
MAXR
321
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.03M 0.02%
+20,000
New +$549K
DPCS
322
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$1.03M 0.02%
100,000
CFIV
323
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$1.02M 0.02%
100,000
-200,000
-67% -$2M
BNZI icon
324
Banzai International
BNZI
$6.43M
$1.01M 0.02%
10
-30
-75% -$3.01M
NVSA
325
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$1.01M 0.02%
100,000

Similar funds

Moore Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Moore Capital Management held 820 positions worth $4.21B, down 1.1% from $4.26B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Moore Capital Management withdrew a net $196M in Q4 2022, closing 277 positions and reducing 63 holdings. Its most notable exit was CrowdStrike, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $264M.

  • Moore Capital Management's largest Q4 2022 buy was State Street SPDR S&P Biotech ETF: 3,182,662 shares worth $264M.
  • Moore Capital Management added most to SolarEdge in Q4 2022, an estimated $63M increase.
  • Moore Capital Management's biggest Q4 2022 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $131M.
  • Moore Capital Management fully exited CrowdStrike in Q4 2022, selling an estimated $91.1M.
  • Moore Capital Management's ten largest holdings make up 39% of its $4.21B portfolio in Q4 2022.
  • Moore Capital Management opened 134 new positions and closed 277 in Q4 2022.
  • Moore Capital Management's portfolio value fell 1.1% quarter-over-quarter to $4.21B.

Based on Moore Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.